By: Alyssa Wilson A new experimental mRNA HIV vaccine by Moderna could begin human trials as early as Thursday, according to the U.S. National Library of Medicine. Moderna is collaborating with the University of Texas at San Antonio, George Washington University, Fred Hutchinson Cancer Research Center and Emory University. RELATED: Tori Cooper Becomes First Black Transgender Woman on Presidential HIV Council For the trials, 56 adults, who do not have HIV, will be enrolled to test the safety of the vaccine. The mRNA- technology being used, mRNA-1644, is based on the mRNA platform in Moderna's COVID-19 vaccine, Clinical Trials Arena reported. 'The uniquely challenging […]
The post Moderna Beginning Human Trials of a mRNA HIV Vaccine appeared first on BNC.
